R. Largillier

Prognostic factors in 1038 women with metastatic breast cancer

R. Largillier, Jean-­Marc Ferrero, J. Doyen et al. · Annals of Oncology · 2008 · 367 citations · Full text

Metastatic Breast Cancer, Breast Oncology, Medicine +3

Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer

P. Fumoleau, R. Largillier, Christine Clippe et al. · European Journal of Cancer · 2003 · 307 citations

Breast Oncology, Oncology, Medicine +6

BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer

Anthony Gonçalvès, Marine Gilabert, E. François et al. · Annals of Oncology · 2012 · 213 citations · Full text

Pancreatic Cancer, Gastrointestinal Oncology, Medicine +9

Imaging in Evaluation of Response to Neoadjuvant Breast Cancer Treatment Benefits of MRI

C. Balu–Maestro, C. Chapellier, A. Bleuse et al. · Breast Cancer Research and Treatment · 2002 · 189 citations

Engineering, Oncologic Imaging, Medical Imaging +10

Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients

Uwe Wagner, Christian Marth, R. Largillier et al. · British Journal of Cancer · 2012 · 182 citations · Full text